The expression of cAMP-dependent protein kinase subunits is differentially regulated during liver regeneration

Autor: Ekanger R, Ok, Vintermyr, Houge G, Te, Sand, Jd, Scott, Eg, Krebs, Ts, Eikhom, Christoffersen T, Ogreid D, Stein Ove Døskeland

Publikováno v: Europe PubMed Central

The levels of the regulatory (RI and RII) and catalytic (C) components of cAMP-dependent protein kinase and of their messages were studied during the first 36 h of liver regeneration after 70% hepatectomy. Both RI alpha mRNA and RII alpha mRNA starte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0579af4bbd26737b6f75837228888d7e
http://europepmc.org/abstract/med/2538442

Khat (Catha edulis)-induced apoptosis is inhibited by antagonists of caspase-1 and -8 in human leukaemia cells.

Autor: Dimba, E. A. O.¹, Gjertsen, B. T.², Bredholt, T.², Fossan, K. O.³, Costea, D. E.¹, Francis, G. W.⁴, Johannessen, A. C.⁵, Vintermyr, O. K.⁶ oIav.vintermyr@heIse-bergen.no

Publikováno v: British Journal of Cancer. 11/1/2004, Vol. 91 Issue 9, p1726-1734. 9p.

A national precision cancer medicine implementation initiative for Norway.

Autor: Taskén K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Kjetil.tasken@medisin.uio.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Kjetil.tasken@medisin.uio.no., Russnes HEG; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Aas E; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.; Division of Health Services, Norwegian Institute of Public Health, Oslo, Norway., Bjørge L; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Blix ES; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway., Enerly E; Department of Research, Cancer Registry of Norway, Oslo, Norway., Fagereng GL; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Flobak Å; The Cancer Clinic, St. Olav University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Gilje B; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Gjertsen BT; Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.; Haematology Section, Department of Medicine, Haukeland University Hospital, Bergen, Norway., Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway., Heix J; CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway., Hovig E; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway., Hovland R; Section for Cancer Genomics, Haukeland University Hospital, Bergen, Norway., Lønning PE; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Meza-Zepeda LA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Mæhle PM; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Nilsen HL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway., Thoresen SØ; CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway.; Merck AB NUF, Oslo, Norway., Widerberg K; CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway., Smeland S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Helland Å; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.

Publikováno v: Nature medicine [Nat Med] 2022 May; Vol. 28 (5), pp. 885-887.

Cancer stem cells – new and potentially important targets for the therapy of oral squamous cell carcinoma.

Autor: Costea, DE, Tsinkalovsky, O, Vintermyr, OK, Johannessen, AC, Mackenzie, IC

Publikováno v: Oral Diseases; Sep2006, Vol. 12 Issue 5, p443-454, 12p, 1 Black and White Photograph, 4 Diagrams, 1 Chart, 1 Graph

Apoptosis in normal and diseased oral tissues.

Autor: Loro, LL, Vintermyr, OK, Johannessen, AC

Publikováno v: Oral Diseases; Sep2005, Vol. 11 Issue 5, p274-287, 14p